ACC, AHA Cut LDL Targets to 55 mg/dL in 2026 Cholesterol Guidelines
Updated
Updated · The Seattle Times · Aug 24
ACC, AHA Cut LDL Targets to 55 mg/dL in 2026 Cholesterol Guidelines
3 articles · Updated · The Seattle Times · Aug 24
Summary
The 2026 ACC/AHA update restores strict LDL goals, telling very high-risk patients with established cardiovascular disease to get below 55 mg/dL and broadening earlier screening.
A 5% 10-year risk score now triggers routine statin treatment, down from 7.5%, after the guideline adopted the AHA PREVENT calculator for adults ages 30 to 79.
Critics say evidence lags the recommendations: only the 55 mg/dL target for the highest-risk group has randomized-trial support, and that study appeared two weeks after release.
Cost and governance concerns are also driving pushback, with tougher targets expected to expand use of expensive non-statin drugs; 16 of 31 writers had relevant conflicts, and the AAFP and ACP declined endorsement.
The guideline still keeps lifestyle first-line—heart-healthy diet, about 150 minutes of weekly exercise, sleep and tobacco avoidance—while urging shared decision-making on medication.
The new PREVENT calculator often lowers risk scores, so why are the 2026 guidelines recommending statins for millions more healthy adults?
With 2026 guidelines pushing ultra-low cholesterol targets, are patients benefiting from better science or just fueling a boom in expensive non-statin drugs?